For the first time, Bioherent demonstrates its photonic diagnostic technology
A pre-Christmas celebration of another kind: Bringing together its founders and investor Bioherent team successfully demonstrated its future integrated photonics based diagnostic technology and marked the publication of its first official white paper.
On Monday the 15th, Bioherent organized a Christmas celebration at its facilities, bringing together the company’s founders, team members, and representatives from Bullnet Capital, one of Bioherent’s main investors. Beyond the festive atmosphere, the event served as an opportunity to present and demonstrate the current state of Bioherent’s photonic diagnostic technology in a real system environment.
During the visit, the Bioherent team carried out a live demonstration of its new platform, showcasing the system’s performance, automation level, and molecular analysis capabilities. The demonstration confirmed the robustness and maturity of the technology, validating key design and performance aspects developed over the past years. The session provided a valuable opportunity for open technical discussion and direct feedback, reinforcing confidence in the platform’s development roadmap.
The event also coincided with an important milestone for the company: the publication of Bioherent’s first whitepaper/technology statement. The document introduces BioXplorer™, Bioherent’s automated silicon-photonics diagnostic and molecular analysis platform, and presents an initial performance statement of the technology. It also offers a preview of AllerWAVE®, Bioherent’s in-vitro diagnostic technology aimed at rapid and highly accurate drug allergy detection.
With this first publication, Bioherent takes an important step toward sharing its scientific and technological progress with the broader diagnostics and biotechnology community. Interested readers are invited to explore the white paper to gain deeper insight into the platform, its capabilities, and Bioherent’s vision for decentralized and accessible in-vitro diagnostics.